Stories about: Paradigm

US researchers develop test vaccine that prevents development of prostate cancer in mice.

A Sydney research team has come up with evidence of inter-generational epigenetic inheritance in humans.

'Drunks beget drunks' is the title of John Whitfield's presentation for the addictions seminar at the IBRO World Congress of Neuroscience, being held in Melbourne in July.

A collaboration between Agilent Technologies and the University of California at Davis (UCD) has developed a new way to characterise glycans in human breast milk.

A team of international scientists has just found the most important molecule in human fertility since the discovery of GnRH.

A Princeton University study suggests it may be possible to deactivate viruses such as HIV indefinitely with the flick of a genetic switch.

PolyNovo Biomaterials and the CSIRO have shaken hands on an agreement to extend their collaboration on a radical new method of repairing damaged cartilage in the knees and joints, using the CSIRO-developed biopolymer NovoSorb.

Delegates to an international tissue-typing workshop in Melbourne this week were told of a remarkable discovery by the University of Perugia immunogeneticist that is beginning to revolutionise tissue- and organ transplantation -- and cure leukaemia.

Melbourne gene-testing company Genetic Technologies (ASX:GTG), currently engaged in a protracted court case with giant US rival Applera over licensing and royalties for GTG's controversial non-coding DNA patents, has a potential rival in its own backyard.

Australia's best-known and most venerable medical research institute, The Walter and Eliza Hall Institute of Medical Research in Parkville, Melbourne, celebrates its 90th anniversary this year. Graeme O'Neill interviewed the Hall's former director, Prof Sir Gustav Nossal, and his successor, Prof Suzanne Cory, about the institute's history and their view of science in Australia today.